Your session is about to expire
← Back to Search
Palliative Radiotherapy for Liver Cancer
Study Summary
This trial is testing whether adding a single dose of radiation to the liver can help reduce pain and discomfort from cancer, compared to receiving standard care alone.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2013 Phase 3 trial • 663 Patients • NCT00102804Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have had stable moderate or severe pain for up to a week.I experience severe pain due to liver cancer, rating it 7-10 in the worst cases.I have had radiotherapy to my upper abdomen that affected more than half of my liver.I have not had chemotherapy or TACE in the last 4 weeks.My liver cancer is widespread, has many tumors, or is very large.Standard cancer treatments are not suitable or effective for me.My colorectal cancer has spread and cannot be removed by surgery or treated with intense radiation.My liver cancer diagnosis was confirmed by specific CT or MRI scans.I am using or willing to use effective birth control or am not of childbearing potential.My liver cancer diagnosis was confirmed through lab tests.My most significant cancer area in the liver matches the painful spot, confirmed by a recent scan.I can attend all treatments and follow-ups for the study.I can start the treatment within 5 days of being chosen for the trial.My pain level is 4 or higher and has been stable recently.My doctor expects me to live more than 3 months.My pain level has been moderate or severe but stable recently.I can care for myself but may not be able to do heavy physical work.I experience moderate pain due to liver cancer, rating it 4-6 out of 10.My liver function score is C10 or less.My scans show cancer in the bile ducts, detected less than 4 months ago.I have not taken targeted cancer drugs like Sorafenib in the last 2 weeks.My cancer diagnosis was confirmed through tissue or cell testing.I am 18 years old or older.I am willing to fill out pain questionnaires in English, French, or another validated language.I haven't had a severe infection needing IV antibiotics in the last 28 days.I can and will complete quality of life surveys in English, French, or another available language.I have had liver-targeted radiotherapy before.I am scheduled for chemotherapy, targeted therapy, or TACE soon.My doctor thinks standard treatments won't work for me or have stopped working.My liver cancer cannot be treated with surgery, RFA, TACE, or high-dose radiation.
- Group 1: Best Supportive Care
- Group 2: Best Supportive Care + RT 8 Gy/1
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there multiple sites hosting this experiment within the city's limits?
"This trial is inviting patients from 7 different medical centres, such as Centre hospitalier regional de Trois-Rivieres in Trois-Rivieres, Ottawa Hospital Research Institute in Ottawa and CHUM-Centre Hospitalier de l'Universite de Montreal in Montreal. Additionally there are additional locations recruiting for this study."
Are there still openings for participants in this clinical experiment?
"As per the clinicaltrials.gov listing, this trial is not currently looking to take on new participants. The study was initially posted in July 23rd 2015 and last updated June 7th 2022; however, there are 3287 other trials actively seeking enrolment at present."
Share this study with friends
Copy Link
Messenger